Skip to content
Penwise

How to choose a GLP-1 tracker app

We make one of these apps, so treat this as an interested party being straight with you rather than a neutral review. What follows is the list of questions we think actually separate a tracker you will still be using in a year from one you abandon in March – written so you can apply it to any app in the category, including ours.

Updated 23 August 2026 · Written by the Penwise team

Start with what you will still want in six months

Nearly everyone starts by logging a date, and nearly everyone finds within two months that a date is not the question. The questions that arrive later are the ones to buy for: which site hurts less, which day the nausea lands, whether the dose is still doing what it did, how many days of pen are left, and what to show a prescriber.

An app that only does dates cannot grow into those. So the first question is not “is it easy to log a shot” – they all are – but “will this answer a question I have not thought of yet”.

The twelve questions

1. Does it record the time of the shot, not just the date?

A Monday morning and a Monday night injection are twelve hours apart on the level curve. Every timing pattern you might later want depends on this, and an app that stores only a date has thrown it away permanently.

2. Does it model your medication level, or just count days?

The difference between “your last shot was Tuesday” and “you are on the downslope” is the difference between a log and a tracker. If it does model a level, ask what it is: a real pharmacokinetic model with per-medication half-lives, or a generic curve applied to everything. Semaglutide and tirzepatide behave differently enough that one curve for both is simply wrong. See tirzepatide and semaglutide half-lives.

3. Does it know your medication, or just accept a name?

Typing “Mounjaro” into a text field is not support. Support means the app knows the dose ladder, the cadence, the half-life and the devices. Ask whether it handles oral doses as a proper route – hiding site and pain fields, switching to a daily schedule – or bolts tablets onto an injection form.

4. Does it understand pens as objects?

This is the sharpest test of depth, because anybody can build a date picker. Does it know how many clicks a full dose is on your specific pen, that a click moves a fixed volume rather than fixed milligrams, how long the pen may be used once started, and how many days of supply you have at the dose you are actually on? See the pen click chart and discard windows.

5. Does it rotate injection sites for you?

A body map is table stakes. What matters is whether it suggests the least recently used site and stores a pain score per site, because that is what turns a year of shots into an answer about your own body rather than a list. See injection sites.

6. Can it record how you felt, in a way that can be analysed?

Free-text notes are unsearchable and unanalysable. Scored side effects and scored measures – appetite, fullness, food noise – can be plotted against the dose cycle. If the app cannot tell you which day after a shot a symptom tends to land, it is a diary.

7. Does it say something only when it has evidence?

An app that reports a pattern from three data points is worse than one that says nothing, because you will believe it. Ask whether insights have a minimum evidence threshold. Quiet is a feature.

8. Where does your data actually live?

This is the question people ask last and should ask first. Does it require an account? Is your medication history stored on a server? Which analytics and advertising SDKs are in the app? What is the retention policy, and what happens to the data if the company is acquired or closes?

An app with no server cannot leak, sell or be compelled to hand over what it does not have. An app with a server may be run by entirely decent people and still be a different risk profile. Both are legitimate choices – but make it a choice rather than a default. See why a GLP-1 tracker should not have a server.

9. Can you get your data out, free?

The single best test of whether an app respects you. Export as CSV or JSON, complete, without a subscription. If your own history is behind a paywall, you are renting your medical record from someone.

10. Can you get your data in?

If you are switching, can it import from where you are? And is the import careful – does re-importing the same file duplicate everything, does it detect date formats and separators rather than assuming, can the whole thing be rolled back? See switching from Shotsy.

11. What does the appointment look like?

At some point you will want to show a prescriber what has been happening. A PDF with dose history, weight trend, adherence and recorded side effects, dated and legible, is worth more than a phone screen scrolled quickly across a desk.

12. What does it really cost?

Compare the yearly price rather than the monthly one, check whether there is a lifetime option, and check what the free tier actually keeps working. Then check what happens if you stop paying – whether the app becomes read-only, whether export still works, and whether your history survives at all.

The categories, honestly

A notes app or a spreadsheet

What most people on GLP-1 medication actually use, and it is free and completely under your control. It cannot rotate sites, cannot remind you, cannot chart anything without work, and cannot answer a timing question. Fine for three months; poor for three years.

A general health or fitness app

Good at weight and steps, unaware of what a titration schedule is, what a KwikPen is, or what food noise means. It will happily let you log a dose in the wrong units.

A dedicated GLP-1 tracker

The category this checklist is about. They differ far more than their screenshots suggest, and the differences are mostly in questions four, seven, eight and nine.

A clinic or telehealth app

Convenient if you get your prescription there, and worth reading carefully on the data question: the organisation holding your log is also the one selling you the medication.

Where Penwise lands

Since we wrote the questions, here are our answers, including the uncomfortable ones.

If cloud sync across devices is a requirement for you, we are the wrong app and we would rather say so here than have you find out in week three.

Run the checklist on us

Free core tracker, no account, full export from day one. Fourteen days of Penwise+ with no card.

Common questions

What should a GLP-1 tracker record beyond the date?
The time of the shot, the medication and dose, which pen it came from, the injection site, a pain score, scored side effects and measures like appetite and food noise, and weight. Those are what make later questions about timing and patterns answerable.
Do I need an app that estimates medication levels?
You do not need one, but it is the feature that changes how the week reads. Knowing you are at the trough rather than that the medication has stopped working is worth a lot, particularly on tirzepatide where the weekly swing is larger.
Is a free GLP-1 tracker good enough?
For logging shots and weight, often yes. What is worth checking is whether the free tier includes exporting your own data – if it does not, the cost of leaving later is your history.
Should I worry about where my medication history is stored?
It is worth a deliberate decision. A medication history is a sensitive record, and an app with no server cannot leak, sell or be compelled to hand over what it never received. An app with a server is not automatically wrong – it is a different risk you should choose knowingly.
Can I move between trackers later?
Only if both ends cooperate. Check that your current app exports complete data as CSV or JSON, and that the new one imports it carefully – detecting formats, avoiding duplicates, and letting you roll back.
Is this comparison impartial?
No, and we have said so at the top. We make Penwise. The checklist is written so you can apply it to any app, including ours, and the section on what Penwise does not do is there because you deserve to find that out before you commit rather than after.

Penwise is a tracking and education tool, not a medical device. Nothing on this page is medical advice, a diagnosis or a recommendation to start, stop or change a dose. Dosing decisions belong to you and your clinician. Ozempic, Wegovy, Rybelsus, Saxenda and Victoza are trademarks of Novo Nordisk; Mounjaro, Zepbound and Trulicity are trademarks of Eli Lilly. Penwise is not affiliated with, endorsed by or connected to either company.

Occasional updates, nothing else.

New features, what we are working on, and the odd thing we learn about GLP-1 tracking. A few times a year at most.

We only use your address for this newsletter. Unsubscribe from any email. Your health data is never involved: it stays on your phone.